Good morning :)
Switch to
Place Order

Venus Remedies Ltd

VENUSREM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹257 cr, stock is ranked 1,690
High RiskStock is 3.12x as volatile as Nifty
190.700.94% (-1.80)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹257 cr, stock is ranked 1,690
High RiskStock is 3.12x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
6.320.58
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.354.320.90%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+327.98+375.99+600.36+606.96-28.58-10.00+61.76+40.74
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Newspaper Advertisements 
Announced OnNov 15, 2022

Venus Remedies Limited has informed the Exchange about Newspaper publication for Financial Results. | Download

Venus Remedies Limited has informed the Exchange about Newspaper publication for Financial Results. | Download

Outcome of Board Meeting 
Announced OnNov 12, 2022

Venus Remedies Limited has informed the Exchange about Board Meeting held on 12-Nov-2022 to consider financial statements for the period ended September 2022 | Download

Venus Remedies Limited has informed the Exchange about Board Meeting held on 12-Nov-2022 to consider financial statements for the period ended September 2022 | Download

Cash Dividend 
Ex. DateSep 23, 2013

Final • Div/Share: ₹ 3

See all events